drugset / Trial / NCT05024721
Study to Evaluate the Efficacy and Safety of HIP2101 in Patients With Acute or Chronic Gastritis
RandomizedParallel-groupDouble-blindTreatment
Summary
The purpose of this study is to investigate the safety and clinical efficacy of HIP2101 in patients with acute or chronic gastritis.
Timeline
- Start
- 2021-08-09
- Primary completion
- 2022-03-07
- Completion
- 2022-03-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Esomeprazole | Small molecule | 10 mg | — |
| Comparator | Famotidine | Other / unclassified | 20 mg | — |